8-Bromo-cyclic adenosine diphosphate ribose
SIGMA/B5416 - 85% (HPLC), lyophilized powder
Synonym: Br-cADP-ribose; Br-cADPR
CAS Number: 151898-26-9
Empirical Formula (Hill Notation): C15H20BrN5O13P2
Molecular Weight: 620.20
MDL Number: MFCD00274402
Linear Formula: C15H20BrN5O13P2
Product Type: Chemical
| assay | 85% (HPLC) |
| color | white |
| form | lyophilized powder |
| InChI | 1S/C15H20BrN5O13P2/c16-15 |
| InChI key | PLQQKRPSINJWTK-VNMBDIRDSA |
| Quality Level | 200 ![]() |
| SMILES string | Nc1ncnc2n([C@@H]3O[C@@H]4 |
| solubility | H2O: 5 mg/mL |
| storage temp. | −20°C |
| Biochem/physiol Actions: | An antagonist of cyclic ADP-ribose (cADPR), and an endogenous metabolite of β-NAD+. cADPR has been shown to regulate calcium release from the endoplasmic and sarcoplasmic reticulum. In cells, cADPR is synthesized by ADP-ribosyl cyclase or CD38, a lymphocyte differentiation antigen. |
| Physical form: | Lyophilized powder containing 10-20% sodium phosphate buffer salts |
| Preparation Note: | Prepared enzymatically |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | 85% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 41106305 |


